<DOC>
	<DOCNO>NCT00315549</DOCNO>
	<brief_summary>This multinational , randomize ( 1:1 ) , double blind , comparator-controlled , 2 parallel treatment group study subject equal 13 year age , Streptococcus pyogenes tonsillitis/pharyngitis ( T/P ) . Each subject receive either telithromycin , 400 mg over-encapsulated tablet , 800 mg daily 5 day penicillin V 250 mg over-encapsulated tablet , 500 mg three time daily 10days . Matching placebo capsule dispense maintain blind treatment groups.A positive rapid identification test streptococcal Group A antigen require subject Visit 1 ( Day 1 ) entry study . Throat swab specimens bacterial culture , identification , antibiotic-susceptibility test take Visits 1 , 3 4 .</brief_summary>
	<brief_title>TELI TAD - Telithromycin Tonsillitis Adolescents Adults</brief_title>
	<detailed_description />
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Tonsillitis</mesh_term>
	<mesh_term>Penicillins</mesh_term>
	<mesh_term>Telithromycin</mesh_term>
	<criteria>Age equal 13 year ; For female subject , follow condition meet : Subject premenarchal surgically incapable bearing child , Subject childbearing potential following condition meet : Have normal menstrual flow within 1 month study entry , Have negative pregnancy test ( urine pregnancy test sensitive least 50 mU/mL , Must agree use accept method contraception throughout study ( sexually active ) ; Clinical diagnosis acute tonsillitis/pharyngitis cause Streptococcus pyogenes base : A positive result rapid detection test Group A streptococcal antigen submission throat swab specimen bacterial culture , identification , antibioticsusceptibility testing ; A sore scratchy throat and/or pain swallowing ( odynophagia ) together least 2 follow clinical sign : Tonsil and/or pharyngeal erythema and/or exudate ; Cervical adenopathy ; Uvular edema ; Fever Symptoms collectively suggest nonstreptococcal T/P ( eg , laryngitis , coryza , conjunctivitis , diarrhea , cough ) ; History positive throat culture Streptococcus pyogenes absence clinical sign symptom T/P ; Infection deep tissue upper respiratory tract ( eg , epiglottitis , retropharyngeal buccal cellulitis , abscess retropharynx , tonsil , peritonsillar area ) suprapharyngeal respiratory tract connect structure ( eg , sinusitis , otitis medium , orbital/periorbital cellulitis ) ; History rheumatic heart disease ; Known congenital prolong QT syndrome ; Known suspect uncorrected hypokalemia ( ≤3 mmol/L [ mEq/L ) hypomagnesemia bradycardia ( &lt; 50 bpm ) ; Known impaired renal function , show creatinine clearance ≤25 mL/min Myasthenia gravis ; History hypersensitivity intolerance macrolides , penicillin , cephalosporin ; Previous enrollment study previous treatment telithromycin ; Children investigator subinvestigator , research assistant , pharmacist , study coordinator , staff , relative thereof directly involve conduct protocol . Is currently treat systemic antibacterial treat systemic antibacterial within 14 day prior enrollment ; Has treat investigational medication within last 30 day ; Has treat rifampicin , phenytoin , carbamazepine , St. John 's wort within last 2 week .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Tonsillitis</keyword>
	<keyword>pharyngitis</keyword>
	<keyword>penicillin</keyword>
	<keyword>telithromycin</keyword>
	<keyword>ketolides</keyword>
	<keyword>clinical trial</keyword>
</DOC>